Although the results from the US cohort did not reach statistical significance, similar trends were observed in patients.
← all excerpts
<i>CTLA4</i> mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood <i>CTLA4</i> levels are associated with poor prognosis in metastatic melanoma patients.
1
—
—